本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

140.45
-4.4300-3.06%
成交量:18.63万
成交额:2,644.70万
市值:90.88亿
市盈率:136.36
高:146.00
开:146.00
低:140.45
收:144.88
52周最高:160.81
52周最低:73.08
股本:6,470.83万
流通股本:6,316.60万
量比:1.34
换手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
净资产收益率:10.98%
总资产收益率:4.55%
市净率:10.80
市盈率(LYR):-68.51

数据加载中...

2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/05

重要事件披露

Form 8-K - Current report
2023/07/04

重要事件披露

Form 8-K - Current report
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/10

重要事件披露

8-K - Current report
2023/03/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/06

重要事件披露

8-K - Current report